Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.59 |
| ▸ | CCR8 | P51685 | 1/20 | 0.59 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.44 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.44 |
| ▸ | GRM5 | P41594 | 3/20 | 0.44 |
| ▸ | METAP2 | P50579 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4538618 | 0.86 | CCR1 (0.42) | CCR1CCR8MAPK14TGFBR1METAP2 | |
| SCHEMBL5020316 | 0.82 | FFAR1 (0.39) | CCR1CCR8MAPK14TGFBR1MEN1 | |
| SCHEMBL4735238 | 0.81 | HSP90AA1 (0.59) | CCR1CCR8GRM5NPC1RAB9A | |
| SCHEMBL9355821 | 0.81 | CCR1 (0.53) | CCR1CCR8MAPK14TGFBR1GRM5 | |
| SCHEMBL9356399 | 0.77 | CCR1 (0.48) | CCR1CCR8MAPK14TGFBR1METAP2 | |
| SCHEMBL4562730 | 0.77 | GRM5 (0.47) | GRM5 | |
| SCHEMBL196966 | 0.77 | CCR1 (1.00) | CCR1CCR8MAPK14TGFBR1GRM5 | |
| SCHEMBL30511194 | 0.77 | CCR1 (1.00) | CCR1CCR8MAPK14TGFBR1GRM5 | |
| SCHEMBL29388304 | 0.77 | CCR1 (1.00) | CCR1CCR8MAPK14TGFBR1GRM5 | |
| SCHEMBL3268715 | 0.76 | CCR1 (0.52) | CCR1CCR8GRM5CYP2A6NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140045873-A1 | NOVEL MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2014-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140045873-A1 | NOVEL MICROBIOCIDES | MSR1, CD209, C3AR1 | CCR1 202/4885CCR8 831/4885MAPK14 4259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.